Pathogenetic Rationale for the Use of Probiotics in Antibiotic-Associated Diarrhea in Children
Journal Title: Здоров`я дитини - Year 2015, Vol 6, Issue 66
Abstract
The article deals with the topical issues of irrational administration of antibiotics in children, development of abnormal side effects and complications, in particular antibiotic-associated diarrhea. The modern means for the prevention and treatment of this group of diseases, in particular the use of probiotics, are presented.
Authors and Affiliations
O. Ye. Chernysheva
Keywords
Related Articles
- EP ID EP218974
- DOI -
- Views 86
- Downloads 0
Diagnosis and Treatment of Community-Acquired Pneumonia in Children
In practice, especially in the outpatient setting, serious problems of pediatrics are early diagnosis and rational therapy of pneumonia in children. The most common pathogens in community-acquired pneumonia are Streptoco...
Optimizing the Treatment of Gastrointestinal Disorders in Food Intolerance in Infants
Advisability of including the polyenzyme dietary supplement Sanzyme syrup in the combination treatment of gastrointestinal manifestations of food intolerance in infants has been studied. It is proved that taking polyenzy...
Cerebral autoregulation and cerebrovascular injury in preterm infants: modern views on pathogenesis, diagnosis and preventive strategies
The review of scientific sources is directed at covering the achievements in understanding the features of cerebral perfusion autoregulation in prematurely born children, establishing the scope of modern methods of its m...
Fever of Unknown Origin in Children: Optimization of Diagnostic Search (Part I)
The first part of the article contains general data about fever of unknown origin, its etiological structure. There is provided the most important clinical information about infectious and oncological diseases, which ini...
Influence of Multiprobiotic on Immunological Parameters in Epstein-Barr Virus Infection in Children
The paper contains results on immunological status investigation of 185 children aged 6–18 years with acute Epstein-Barr virus infection in the form of infectious mononucleosis; results of these children’s treatment with...